RYOIX : RYDEX BIOTECHNOLOGY INV

 
 
 
 
5

ZACKS RANK: 5 - STRONG SELL

Ticker: RYOIX
Manager: Team Managed
Manager Since: NA
NAV (07/23/2014): 69.17
Objective: Health Care - Equity
Peer: HL MG
Net Assets ($mil): 313.32
Inception: 04/01/1998
RYOIX : Description

The fund was incepted in April 1998 and is managed by Rydex Global Advisors. The fund seeks capital appreciation by investing in companies that are involved in the biotechnology industry, including companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products or services (biotechnology companies). The fund invests substantially all of its assets in equity securities of biotechnology companies that are traded in the United States. The fund may also engage in futures and options transactions, purchase ADRs and U.S. government securities, and enter into repurchase agreements. Dividends and capital gains, if any, are distributed annually.

RYOIX : Composition - 07/14
Stocks 99.82%
Foreign Stocks 2.65%
Cash 11.15%
Bonds 0.00%
Foreign Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other -10.97%
Foreign Hedged 0.00%
Composition Horizontal Bar Chart
RYOIX : Style Analysis - 07/14
Large Growth 29.58%
Large Value 0.00%
Small Growth 8.09%
Small Value 0.00%
Foreign Stock 29.58%
Emerging Market 0.00%
Precious Metals 0.00%
Intermediate Bond 25.07%
High Yield Bond 0.00%
Foreign Bond 0.00%
Style Analysis Horizontal Bar Chart
RYOIX : Risk Analysis
Beta v. S&P 500 1.00
Beta v. EAFE 0.03
Beta v. Barclays Agg Bond 1.35
Alpha 3 Yr 15.57
Alpha 5 Yr 8.28
R-Sq 3 Yr 0.30
R-Sq 5 Yr 0.40
Std Dev 3 Yr 21.33
Std Dev 5 Yr 21.35
Sharpe 3 Yr 1.61
Sharpe 5 Yr 1.39
RYOIX : Fees
Expense Ratio 1.36
% Max Load NA
% Min Load NA
% Deferred Load NA
% Redemption NA
% Max 12 B1 Fee 0.00
% Max Mgt Fee 0.85
RYOIX : Purchase Choices:
Min Initial Investment 2500
Min Subsequent Investment 0
RYOIX : Returns Analysis - Annual

Line chart

  2004200520062007200820092010201120122013YTD
NAV ($) 20.1222.4821.7923.0320.6024.6227.2230.3241.4064.0369.17
Total Return (%) 1.8711.72-3.075.69-10.5519.5110.5611.3836.5454.6613.44
Annual Dividend Yield (%) 0.000.000.000.000.000.000.000.000.000.000.00
Relative Performance
Rel Performance-S&P500(%) -90.0068.38-188.661.96264.57-69.07-45.0392.89205.50222.8063.32
Rel Performance-Obj.Ret.(%) -69.0727.66-68.05-31.74131.46-23.6325.3636.40173.1183.5418.70
Ret.Quintile vs Obj(1 is best) 53541421121
Turnover, Yields, and Gains
Fund Assets Net($mil) 114758391731784652166276313
Annual Turnover (%) 548.00585.00320.00269.00193.00370.00316.00337.00333.00197.00119.00
Annual Dividend Paid ($) 0.000.000.000.000.000.000.000.000.000.000.00
Annual Capital Gains Paid($) 0.000.000.000.000.000.000.000.000.000.000.00
RYOIX : Returns Analysis - Trailing Total Return
  1 Month 3 Month 6 Month YTD 1 Year 3 Year 5 Year 10 Year 15 Year 20 Year
Total Return (through 07/14) 8.43% 6.09% 13.44% 13.44% 40.69% 31.56% 26.96% 13.66% 11.78% NA
Ret. Percentile vs. Obj. (1 is best) 3 10 15 15 16 8 19 13 21 NA
RYOIX : Stock Portfolio Snapshot - 07/14
Average Price/Earnings 40.78
Average Price/Book 5.76
Average EPS Growth 16.04
Average Market Value 27,811.00
RYOIX : Stock Sector Breakout - 07/14
Stock Sector Breakout
RYOIX : Top Holdings - 07/14
Name Weight Shares
GILEAD SCIENCES INC 7.31 443,536
AMGEN INC 6.79 236,654
BIOGEN IDEC INC 5.76 80,933
CELGENE CORP 5.27 162,157
BIOMARIN PHARMACEUTICAL 2.12 133,494
ALEXION PHARMACEUTICALS INC 3.74 105,774
ILLUMINA INC 3.02 87,246
VERTEX PHARMACEUTICALS INC 2.82 171,152
REGENERON PHARMACEUTICALS 3.77 54,019